# European oncology congress: therapeutic advances and access to care

> Le 26 octobre 2026, plusieurs avancées thérapeutiques contre le cancer ont été annoncées : une immunothérapie prolongeant la survie dans le cancer du poumon à petites cellules, une nouvelle famille de médicaments pour les cancers gynécologiques et un vaccin personnalisé contre le mélanome montrant des résultats prometteurs. Le 29 octobre, le professeur Jean-Jacques Kiladjian a souligné le décalage entre ces annonces de traitements prometteurs et leur accès effectif pour les patients. Le 30 octobre, ces avancées, dont le vaccin contre le mélanome, ont été présentées lors d'un sommet européen de l'oncologie.

**In brief**: Ongoing story bringing together 5 events nationwide, followed from 26 October 2026 to 30 October 2026. 17 articles from 12 sources (health); last updated on 30 October 2026 at 12:00.

- Status: ongoing
- Category: Health
- Place: Nationwide
- First detected: 26 October 2026 at 11:15
- Updated: 30 October 2026 at 12:00
- Web page: https://acturadar.com/en/stories/172-european-oncology-congress-therapeutic-advances-and-access-to-care

## Timeline (5 events)

### 26 October 2026 — [New immunotherapy extends survival in lung cancer](https://acturadar.com/en/events/717-new-immunotherapy-extends-survival-in-lung-cancer.md)

Two new treatments for small cell lung cancer improve patients' survival, with a survival gain described as "never seen".

2 sources, 4 articles · Nationwide

### 26 October 2026 — [A new family of drugs against gynecological cancers](https://acturadar.com/en/events/842-a-new-family-of-drugs-against-gynecological-cancers.md)

A new family of treatments raises hope in the management of gynecological cancers.

1 sources, 1 articles · Nationwide

### 26 October 2026 — [A promising tailor-made vaccine against melanoma recurrences](https://acturadar.com/en/events/1370-a-promising-tailor-made-vaccine-against-melanoma-recurrences.md)

A personalized vaccine against melanoma shows promising results, with 82% of treated patients not experiencing a recurrence.

9 sources, 10 articles · Nationwide

### 29 October 2026 — [Cancer research: between treatment promises and delays in access to care](https://acturadar.com/en/events/3625-cancer-research-between-treatment-promises-and-delays-in-access-to-care.md)

Following the European oncology congress, Professor Jean-Jacques Kiladjian explains the gap between announcements of promising treatments and their effective access for patients.

1 sources, 1 articles · Nationwide

### 30 October 2026 — [Therapeutic advances against cancer presented at European oncology summit](https://acturadar.com/en/events/4639-therapeutic-advances-against-cancer-presented-at-european-oncology-summit.md)

A melanoma vaccine and promising new treatments are among the medical advances presented at a European oncology summit.

1 sources, 1 articles · Nationwide

---

Cite as: Acturadar, “European oncology congress: therapeutic advances and access to care”, https://acturadar.com/en/stories/172-european-oncology-congress-therapeutic-advances-and-access-to-care
Methodology: https://acturadar.com/en/methodology